BACKGROUND: Although injection drug use is known to result in a range of health-related harms, including transmission of HIV and fatal overdose, little is known about the possible role of synthetic drugs in injection initiation. We sought to determine the effect of crystal methamphetamine use on risk of injection initiation among street-involved youth in a Canadian setting. METHODS: We used Cox regression analyses to identify predictors of injection initiation among injection-naive street-involved youth enrolled in the At-Risk Youth Study, a prospective cohort study of street-involved youth in Vancouver, British Columbia. Data on circumstances of first injection were also obtained. RESULTS: Between October 2005 and November 2010, a total of 395 drug injection-naive, street-involved youth provided 1434 observations, with 64 (16.2%) participants initiating injection drug use during the follow-up period, for a cumulative incidence of 21.7 (95% confidence interval [CI] 1.7-41.7) per 100 person-years. In multivariable analysis, recent noninjection use of crystal methamphetamine was positively associated with subsequent injection initiation (adjusted hazard ratio 1.93, 95% CI 1.31-2.85). The drug of first injection was most commonly reported as crystal methamphetamine (14/31 [45%]). INTERPRETATION: Noninjection use of crystal methamphetamine predicted subsequent injection initiation, and crystal methamphetamine was the most commonly used drug at the time of first injection. Evidence-based strategies to prevent transition to injection drug use among crystal methamphetamine users are urgently needed.
BACKGROUND: Although injection drug use is known to result in a range of health-related harms, including transmission of HIV and fatal overdose, little is known about the possible role of synthetic drugs in injection initiation. We sought to determine the effect of crystal methamphetamine use on risk of injection initiation among street-involved youth in a Canadian setting. METHODS: We used Cox regression analyses to identify predictors of injection initiation among injection-naive street-involved youth enrolled in the At-Risk Youth Study, a prospective cohort study of street-involved youth in Vancouver, British Columbia. Data on circumstances of first injection were also obtained. RESULTS: Between October 2005 and November 2010, a total of 395 drug injection-naive, street-involved youth provided 1434 observations, with 64 (16.2%) participants initiating injection drug use during the follow-up period, for a cumulative incidence of 21.7 (95% confidence interval [CI] 1.7-41.7) per 100 person-years. In multivariable analysis, recent noninjection use of crystal methamphetamine was positively associated with subsequent injection initiation (adjusted hazard ratio 1.93, 95% CI 1.31-2.85). The drug of first injection was most commonly reported as crystal methamphetamine (14/31 [45%]). INTERPRETATION: Noninjection use of crystal methamphetamine predicted subsequent injection initiation, and crystal methamphetamine was the most commonly used drug at the time of first injection. Evidence-based strategies to prevent transition to injection drug use among crystal methamphetamine users are urgently needed.
Authors: Crystal M Fuller; Luisa N Borrell; Carl A Latkin; Sandro Galea; Danielle C Ompad; Steffanie A Strathdee; David Vlahov Journal: Am J Public Health Date: 2005-04 Impact factor: 9.308
Authors: Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Veronica M Frajzyngier; Samuel R Friedman; Don C Des Jarlais Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: M Teresa Brugal; Gregorio Barrio; La Fuente Luis De; Enrique Regidor; Luis Royuela; Josep M Suelves Journal: Addiction Date: 2002-03 Impact factor: 6.526
Authors: Elena Argento; Steffanie A Strathdee; Shira Goldenberg; Melissa Braschel; Julio Montaner; Kate Shannon Journal: Drug Alcohol Depend Date: 2017-04-19 Impact factor: 4.492
Authors: Evan B Cunningham; Brendan Jacka; Kora DeBeck; Tanya L Applegate; P Richard Harrigan; Mel Krajden; Brandon D L Marshall; Julio Montaner; Viviane Dias Lima; Andrea D Olmstead; M-J Milloy; Evan Wood; Jason Grebely Journal: Drug Alcohol Depend Date: 2015-04-20 Impact factor: 4.492
Authors: Brendan Jacka; Tanya Applegate; Art F Poon; Jayna Raghwani; P Richard Harrigan; Kora DeBeck; M-J Milloy; Mel Krajden; Andrea Olmstead; Jeffrey B Joy; Brandon D L Marshall; Kanna Hayashi; Oliver G Pybus; Viviane Dias Lima; Gkikas Magiorkinis; Julio Montaner; Francois Lamoury; Gregory J Dore; Evan Wood; Jason Grebely Journal: J Hepatol Date: 2016-02-26 Impact factor: 25.083
Authors: Scott E Hadland; Kora DeBeck; Thomas Kerr; Paul Nguyen; Annick Simo; Julio S Montaner; Evan Wood Journal: J Adolesc Health Date: 2014-06-09 Impact factor: 5.012
Authors: William Damon; Ryan McNeil; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Kanna Hayashi Journal: J Public Health (Oxf) Date: 2019-03-01 Impact factor: 2.341